Healthcare Sales & Marketing Network News: Requip

Searching News Database: Requip

HSMN NewsFeed - 13 Apr 2009
XenoPort Announces Election of Co-Promotion Option for Solzira
Biopharmaceuticals

HSMN NewsFeed - 13 Jun 2008
U.S. FDA Approves Requip(R) XL(TM), the First and Only Oral Once-Daily Non-Ergot Dopamine Agonist for Parkinson's Disease
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 7 May 2008
Mylan Announces Final FDA Approval for Ropinirole Hydrochloride Tablets
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 30 Nov 2007
Teva Announces Tentative Approval of Generic Requip(R) Tablets
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 17 Sep 2007
CEO and President David Brand to Leave Cardiokine
Biopharmaceuticals Personnel

HSMN NewsFeed - 2 Apr 2007
Once Daily, Extended-Release Ropinirole Improves Parkinson's Symptoms in Patients not Optimally Controlled With Levodopa
Biopharmaceuticals Neurology

HSMN NewsFeed - 8 Feb 2007
GlaxoSmithKline and XenoPort Announce Agreement on Late-Stage Compound for RLS and Neuropathic Pain
Biopharmaceuticals

HSMN NewsFeed - 6 Sep 2006
Former Chiron Exec Joins APT Pharmaceuticals as CEO
Biopharmaceuticals Personnel

Return to NewsFeed

Additional items found! 9

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 9 additional stories matching:
Requip
(Password required)

FindReps - Find Great Medical Independent Sales Reps without recruiter fees.

FindReps - available on the Apple App Store for iPhone and iPad.